Noxopharm Limited
(ASX:NOX) Executive Chairman and CEO, Dr Graham Kelly, Chief Medical Officer, Dr Gisela Mautner and Chief Commercial Officer, Alex Hunter provide an update on the company’s progress, clinical trials and strategy.
Topics covered: - Corporate overview
- Clinical development program
- Drug pipeline program
- Clinical development strategy
- Commercial and financial perspective
